ELIZABETH SCHIFFLI: Open Payments
NPI 1194142240 · FORT WAYNE, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$731 in 33 payments from 13 companies in 2025. Trend: 2023 $628 · 2024 $886 · 2025 $731
Food & beverage: $731
| Company | Payments | Amount |
|---|---|---|
| Verona Pharma, Inc. | 5 | $171 |
| AstraZeneca Pharmaceuticals LP | 8 | $168 |
| Regeneron Healthcare Solutions, Inc. | 5 | $107 |
| Amgen Inc. | 3 | $50 |
| United Therapeutics Corporation | 2 | $40 |
| GlaxoSmithKline, LLC. | 2 | $39 |
| Viatris Specialty LLC | 2 | $30 |
| Grifols USA, LLC | 1 | $26 |
| Baxter Healthcare | 1 | $25 |
| Insmed, Inc. | 1 | $24 |
Products named: Ohtuvayre, DUPIXENT, TEZSPIRE, AIRSUPRA, Tyvaso, NUCALA, FASENRA, YUPELRI.
Industry payments across IN — which companies pay providers there.
